TCBP (TC BioPharm (Holdings) Plc) Sof foyda

TCBP (TC BioPharm) - kompaniyaning tovar belgisi

TC Biopharm onkologiya sohasida yetakchilikni saqlab qolish uchun eksklyuziv T-hujayralarni modifikatsiya qilish patentlaridan foydalanmoqda. Kompaniyaning foyda marjalari joriy tendentsiyalarni aks ettirmoqda va ko'rsatkich 0.00 darajasida saqlanmoqda. Bu qon saratoni uchun hamyonbop allogeneik davolash usullarining intensiv ishlab chiqilishi bilan bog'liq. Shu bilan birga, biznes ESG standartlarini joriy etib, bio-chiqindilarni axloqiy yo'llar bilan yo'q qilishni va klinik sinovlar davomida qat'iy rioya qilishni ta'minlamoqda.

TCBP (TC Biopharm) Sof foyda tarixi 28.04.2023dan 29.03.2025gacha

TC BioPharm (TCBP) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari TC BioPharm Ltd|TCBP - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi TC Biopharm|TCBP - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati TC BioPharm|TCBP - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi tcbiopharm.com|TCBP - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati TC Biopharm|TCBP - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati TC BioPharm (Holdings) Plc|TCBP - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar TC Biopharm|TCBP - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi TC BioPharm|Shoshilinch likvidlik tcbiopharm.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
TCBP - Sof daromad
Kompaniyaning jamlanma tahlili:TC Biopharm
TC BioPharm (Holdings) PLC asosiy tovari

Investorlar biznesning barqarorligini bozor buzilishlarisiz operatsion modelning haqiqiy samaradorligini aks ettiruvchi sof foyda dinamikasi orqali bahlamoqdalar. 0.00 ning joriy qiymati barcha xarajatlar chegirib tashlanganidan keyingi yakuniy moliyaviy natijani aks ettiradi, bu esa hujayralar terapiyasi ishlab chiquvchisi TC Biopharm (TCBP) uchun tadqiqot va ishlanmalar (R&D) bosqichidan immunoterapiya dori vositalarini tijoratlashtirishga o'tish davrida kompaniyaning foyda marjasini belgilovchi muhim omildir.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PGEN: Sof daromad|Pharming Corp - Soliqlar to‘langandan keyingi foyda|NKTR: Sof foyda|Sof daromad upstreambio.com|Sof daromad ZBIO|IMNM: Yakuniy foyda|Sof foyda GOSS|Kompaniyaning sof foydasi KALV (KalVista Corp)|Sof foyda SEPN (Septerna Inc)|Sof moliyaviy natija pieris.com (PVLA)|SVRA - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Rigel Pharma|AnaptysBio Corp (ANAB) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda ATXS (Astria Corp)|ENGN (enGene Holdings Inc.) - Sof foyda|RAPT: Yakuniy foyda|Sof foyda JBIO|Sof foyda Aclaris Therapeutics Inc. (ACRS)|Kompaniyaning sof foydasi Kyverna KYTX|Yakuniy foyda TLSA|CABA - Kompaniyaning sof foydasi|ventyxbio.com (VTYX) - Sof daromad|THTX (Theratechnologies) - Sof daromad|AVTX: Soliqlar to‘langandan keyingi foyda|ELDN (Eledon) - Sof foyda|Sof daromad Agenus, Inc (AGEN)|Sof foyda CLYM|Kompaniyaning sof foydasi ZURA (zurabio.com)|Kompaniyaning sof foydasi aTyr Pharma ATYR|ADAG (Adagene Inc) - Soliqdan keyingi foyda|IMA - Kompaniyaning sof foydasi|Soliqdan keyingi foyda STTK|EQ: Sof foyda|Connect Biopharma Holdings Limited - Yakuniy foyda|IMUX (Immunic Therapeutics) - Sof foyda|Sof foyda Atara Biotherapeutics Inc|Kompaniyaning sof foydasi InflaRx N.V. (IFRX)|XFOR (X4 Pharmaceuticals, Inc) - Yakuniy foyda|Kompaniyaning sof foydasi Adicet Bio, Inc. ACET|CELU - Sof daromad|INmune Bio - Sof foyda|BRNS - Sof foyda|KZR (Kezar Life Sciences, Inc) - Sof daromad|SAB Biotherapeutics Inc - Yakuniy foyda|AKTX (Akari Therapeutics) - Sof foyda|Enlivex Therapeutics, Ltd. (ENLV) - Sof moliyaviy natija|Kompaniyaning sof foydasi Q32 Bio Inc. (QTTB)|Sof daromad GeoVax Labs GOVX|Kompaniyaning sof foydasi Edesa EDSA|IBIO - Sof daromad|CARM: Sof daromad|XTLB - Sof foyda|boltbio.com (BOLT) - Kompaniyaning sof foydasi|Kompaniya foydasi HCWB|APVO (Aptevo Therapeutics, Inc.) - Sof foyda|Kompaniyaning sof daromadi aimimmuno.com AIM|Sof daromad ADTX (Aditxt)|Soliqlar to‘langandan keyingi foyda GRI|Sof foyda XRTX (XORTX Therapeutics)|HIND - Sof daromad|REVB: Sof daromad|Yakuniy foyda INDP (Indaptus Corp)|SCNI: Sof foyda|CALI (CalciMedica) - Kompaniyaning sof foydasi|AFMD (Affimed NV) - Sof foyda|Allakos Therapeutics (ALLK) - Sof moliyaviy natija|Kompaniyaning sof foydasi HOOKIPA Pharma Inc. (HOOK)|IGMS - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi iTeos Therapeutics ITOS|OCEA (oceanbiomedical.com) - Soliqdan keyingi foyda|Third Harmonic Bio, Inc. - Sof foyda